Clinical Challenges: When to Add Immunotherapy in Breast Cancer – MedPage Today

For breast cancer patients, the current indications for immune checkpoint inhibitors (ICIs) are generally limited to triple-negative breast cancer (TNBC), both in high-risk early-stage disease or in the advanced setting for tumors with certain levels of…

Click here to view the original article.